Momenta Pharmaceuticals buy Stakeholder
Start price
20.08.20
/
50%
€43.80
Target price
04.11.21
-
Performance (%)
2.28%
End price
17.08.21
-
Summary
This prediction is currently being closed. With a performance of 2.28%, the BUY prediction by Stakeholder for Momenta Pharmaceuticals is trending in the right direction. Stakeholder has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Momenta Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | 0.437% | 5.897% | 8.047% | 65.579% |
| iShares Nasdaq 100 | 1.057% | 0.920% | 28.466% | 90.185% |
| iShares Nikkei 225® | 1.769% | 1.228% | 47.574% | 84.991% |
| iShares S&P 500 | 0.368% | 1.920% | 23.200% | 70.760% |
Comments by Stakeholder for this prediction
In the thread Momenta Pharmaceuticals diskutieren
Johnson&Johnson möchte für umgerechnet 5,5mrd. Momenta kaufen – J&J ist bereit 52,50 pro Aktie anzubieten

